Human herpesvirus (HHSV) 
HSV and HCMV, members of the Herpesviridae family, are causal agents of ubiquitous infections. Although mostly asymptomatic, their common feature is to dangerously affect childbirth if infection occurs during pregnancy or delivery.
For both viruses, primary infection during pregnancy is a major public health issue because of severe risks for the child. After primary infection the viruses never leave the host and enter into a latency or persistence state which is the key to the immunopathogenesis of the infection.
Prevention and treatments are available, but for both infections, screening exposed women is controversial because the risk for neonatal contamination is not clearly estimated.
We will revew the pathogenesis of both viruses for pregnant women and expose intervention strategies. Herpesviridae family, composed of more than 100 members, is divided in 3 subfamilies, 13 -and y-herpesvirinae, according to their biological criteria, like cycle duration, latency or persistence in the host, and their oncogenic properties.
Eight herpesviruses infect the human. Herpes- 6 The differential orientation of those single units allows 4 isomeres for each genome. 7 These genomes contain 100 opening reading frame (ORF) for HHSV and more than 200 ORF for HCMV. HSV1 and HSV2 share more than 50% of nucleotidic sequence homology. 8 The leader of the subfamily of cx Herpesviridae, HHSV1 is characterized by a broad host spectrum in vitro, narrow in vivo, a short viral cycle, latency and reactivation properties, a viral thymidine kinase mediated neurovirulence 9 and a gD and gB mediated neuroinvasion. 1 The leader of the subfamily of [ CID frequency is about 0.03%. Contamination occurs through ascension from urogenital secretions or mother's viremia, into the placenta by blood leukocytes. 44 The virus reaches the fetus through the placenta barrier and replicates in elected organs, mostly kidneys, 4s,46,47 and is excreted in the amniotic fluid.
The most severe cases result from a maternal p.i. during pregnancy. Transmission rate to the fetus varies from 30 to 50%. 42, 48, 49, 50 The risk for p.i. during pregnancy varies from to 13% with the studies and the countries, s,sz,s3 and increases with the number of pregnancies (2.3% at first pregnancy vs. 3.8% at the second). 49 The presence of endometritis or ovaritis implies the possible fetal infection by viral ascension or proximity. Asymptomatic neonatal HCMV infections relate to viral reinfections and particularly reactivations during the third trimester of pregnancy.More than 10% of pregnant HCMV seropositive women excrete the virus through uterine cervix during that period.
During secondary infections, after reactivation, persistence of chronic infection or reinfection by an other virus strain, s4,ss the maternal fetal transmission rate varies from 0.5% to 10%. 48 So the only proposition should be therapeutic abortion or long term pediatric follow up until current studies can bring a consensus. 69 The lack of an active vaccine against HCMV is stressed. Vaccine completion has become a priority of virologic fundamental research. 7 
